Bipolar II Disorder SOAP Note: Adolescent Psychiatric Case
This paper presents a comprehensive psychiatric SOAP note evaluation of a 15-year-old female referred for worsening behavioral and academic difficulties. The case explores a chief complaint of ineffective ADHD medication, and through detailed subjective history, objective findings, and mental status examination, arrives at a primary diagnosis of bipolar II disorder co-occurring with ADHD. Three differential diagnoses — bipolar disorder, ADHD (predominantly inattentive presentation), and major depressive disorder — are systematically evaluated against DSM-5 criteria. The treatment plan includes initiation of lithium carbonate, continuation of methylphenidate (Concerta), and cognitive-behavioral therapy. Patient education on medication risks, adherence, and safety planning is also addressed.
- Subjective: Chief Complaint and History of Present Illness: Patient history, ADHD background, mood cycling symptoms
- Review of Systems and Current Medications: Current medications, allergies, and systems review
- Objective Findings and Diagnostic Results: Lab results ruling out organic causes of symptoms
- Mental Status Examination and Diagnostic Impression: MSE findings and three differential diagnoses evaluated
- Reflections on Treatment Considerations: Lithium risks and pediatric prescribing considerations
- Case Formulation and Treatment Plan: Lithium, CBT, education, safety planning, and follow-up
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The case systematically works through three differential diagnoses using DSM-5 criteria, demonstrating disciplined clinical reasoning rather than jumping to a conclusion.
- The treatment plan addresses multiple dimensions — pharmacotherapy, psychotherapy, patient education, medication interactions, safety planning, and follow-up labs — reflecting comprehensive psychiatric care.
- The reflections section shows critical awareness of risk-benefit tradeoffs specific to the pediatric population, particularly concerning lithium use in a young patient.
Key academic technique demonstrated
This paper demonstrates evidence-based differential diagnosis: each diagnostic candidate is introduced, matched against established criteria (DSM-5), and systematically accepted or eliminated based on the clinical evidence presented. This method prevents premature diagnostic closure and models the structured reasoning expected of a psychiatric nurse practitioner.
Structure breakdown
The paper follows the standard SOAP format — Subjective (chief complaint, HPI, medications, ROS), Objective (diagnostic test results), Assessment (MSE and differential diagnoses), and Plan (treatment, education, safety, follow-up). A reflections section bridges the assessment and plan, adding an evaluative layer on pharmacological considerations for a pediatric patient. This structure is commonly required in PMHNP clinical training programs.
Subjective: Chief Complaint and History of Present Illness
CC (Chief Complaint): The client presents accompanied by her mother. The chief complaint, as reported by the mother, is that the client's medications "do not seem to be working." Her grades have been on a consistent downward trend, from As to Bs and currently Ds. Conflicts with her sister and mother at home have escalated to the point that her mother describes her as "mean" and "nasty," and she has lost many of her long-standing friends. The client, for her part, says she has no particular complaints and that her mother is exaggerating.
HPI: The client is a 15-year-old white female referred by her primary care physician (PCP) due to worsening difficulties at school and at home. The client first saw a psychiatrist at the age of 7, when she was evaluated for attention-deficit hyperactivity disorder (ADHD) because of distractibility, impulsivity, and restlessness. After a series of failed behavioral interventions, the client was placed on methylphenidate-based medication at the age of 8. For the next six years, her social life and academic scores improved, and she was much like any other child her age as long as she took her medication.
Over the past year, however, the client has stopped being a bubbly teenager and is moody most of the time. She spends days by herself, locked in her room, and hardly speaks to anyone. During these episodes, she is uninterested in everything, constantly complains that her family and friends do not like her, and sleeps most of the day. Her mother reports that for a week or two the client would be "bubbly," laugh at nearly anything, and enthusiastically help with household chores. She would then sink into a week or so of persistent sadness and irritability, during which she is constantly yelling at her sister and mother to the point that everyone is "walking on eggshells."
At around age 14, her therapist increased her dosage of ADHD medication. The client's family history is pertinent for bipolar disorder (manic-depressive illness); her mother indicates that the client's father, whom the client has never met, was treated with lithium when they were together.
Substance Use: The client denies use of any illicit substances or alcohol.
References
APA (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: American Psychiatric Association.
Brunkhorst-Kanaan, N., Verdenhalven, M., Kittel-Schneider, S., Vainieri, S., Reif, A., & Grimm, O. (2020). The Quantified Behavioral Test — A confirmatory test in the diagnostic process of adult ADHD. Frontiers in Psychiatry, 11(1), 216–235.
Chiang, K., Tsai, J., Liu, D., Hin, C., Chiu, H., & Chou, K. (2017). Efficacy of cognitive behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials. PLOS ONE. doi:10.1371/journal.pone.0176849
Culpepper, L. (2014). The diagnosis and treatment of bipolar disorder: Decision-making in primary care. The Primary Care Companion for CNS Disorders, 16(3). doi:10.4088/PCC.13r01609
FDA (2018). Lithium carbonate: Highlights of prescribing information. Food and Drug Administration. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.pdf
Create your account
Always verify citation format against your institution’s current style guide requirements.